Emerald Advisers »

Peregrine Pharmaceuticals shares owned by Emerald Advisers

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $17M 1.4M 11.38

More positions owned by Emerald Advisers

Ftai Aviation (FTAI)
Freshpet (FRPT)
Carpenter Technology Corporation (CRS)
Varonis Sys (VRNS)
Insmed (INSM)
Q2 Holdings (QTWO)
Credo Technology Group Holding (CRDO)
RadNet (RDNT)
Brp Group (BWIN)
AeroVironment (AVAV)
Allegheny Technologies Incorporated (ATI)
Palomar Hldgs (PLMR)
Kratos Defense & Security Solutions (KTOS)
Impinj (PI)
Livanova Plc Ord (LIVN)

View all positions for Emerald Advisers

Top funds holding Peregrine Pharmaceuticals

BlackRock
BlackRock
Point72 Asset Management
Vanguard Group
AltraVue Capital
State Street Corporation
Royal Bank of Canada
First Light Asset Management
Palisade Capital Management
Snyder Capital Management
Portolan Capital Management
Geode Capital Management
Emerald Advisers
Citadel Advisors
Harbor Capital Advisors

View all funds holding Peregrine Pharmaceuticals